Although the related specific mechanisms on how LDLR signalling might affect LEC function remain to be understood, our data suggest that LDLR per se could have a functional role in the early stage of lymphatic dysfunction, thus corroborating a novel pleiotropic effect of PCSK9 in arterial disease. Here, PCSK9 is linked to arterial disorder.